Navigation Links
Best Practices in Patient Recruitment and Retention for Diabetes Trials, New Life Science Webinar Hosted by Xtalks
Date:11/8/2013

Toronto, Canada (PRWEB) November 08, 2013

Despite the growing prevalence of diabetes around the world, clinical trials face significant recruitment challenges brought on by increasing competition for patients, eligibility criteria and stricter regulatory requirements. Well over 200 drugs are currently in development for diabetes and related conditions. Given this level of drug development activity, as many as 500,000 patients are needed to enroll in these trials. To reduce the risk of costly enrollment delays, tailored recruitment strategies need to proactively address protocol challenges, consider patient motivations and complement local recruitment practices.

Missing data may also have costly consequences at the end of a study. Retention of patients has been recently highlighted by regulatory pressures to collect final status on outcomes trials. To reduce the risk of dropout or lost to follow-up, addressing protocol challenges up front may help to mitigate this risk. Retention strategies should be designed to reduce barriers to enrollment, promote protocol compliance and ensure a means of follow up with patients.

The discussion will include ways to develop targeted strategies with the potential to increase enrollment rates and reduce lost to follow-up by:

  •     Using patient insights to identify patient motivations and anticipate protocol challenges.
  •     Assessing site potential and leveraging site intelligence to customize strategies to the local level.
  •     Exploring of the use of digital outreach and engagement tactics.
For more information about this event or to register, visit: http://xtalks.com/patient-recruitment-retention-diabetes-trials.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx.

Contact:
Michelle Tran, Marketing Manager
+1 (416) 977-6555 ext 284
mtran(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11309631.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
2. Innovation Leaders from Across Industries will Convene to Share Best Practices and Breakthrough Successes at Open Innovation Leadership Summit
3. Reno Efficient Sustainable Practices Selected to Provide Water and Energy Conservation Services To the County of San Diego
4. Best Practices, LLC Issues New Report and Webinar on Managing Healthcare Reform through Effective Engagement with the Government Ecosystem
5. First Suit Against Nobel Prize Organization Citing Defamation And Unfair Competition Practices Is Filed
6. How to Ensure Pharmacovigilance Practices are Compliant with Global Safety Requirements: Challenges in Asia-Pacific
7. BioInformatics LLC New Market Report – Best Practices Guide for Advertising to Life Scientists
8. Local Leaders Convene in Boston to Share Industry Best Practices in Second “Business of Big Data” Summit
9. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
10. Alacrita Aggregates the Life Science Practices of Two Consulting Firms and Appoints Simon Turner Ph.D FRSC as Partner
11. Best Practices for Conducting Extractable and Leachable Studies, new life sciences webinar hosted by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the ... today announced its financial results for the fourth quarter and ... Financial Highlights Total sales in the ... or increased by 13.6% in USD terms to $77.6 million ... Gross profit increased by 13.3% to $46.8 million ...
(Date:2/23/2017)... and NEW YORK , ... Lumeon , a leading digital health company, ... a provider of telemedicine and remote patient monitoring, ... for telemedicine reimbursements.  DN Telehealth ... patients, in real-time, extending consultations beyond a physical ...
(Date:2/23/2017)... TORONTO , Feb. 23, 2017 /PRNewswire/ - The ... Institute for Cancer Research (OICR) are pleased to report ... Series A financing, with Johnson & Johnson Innovation – ... investors include venture groups HealthCap, TPG Biotechnology Partners, and ... ...
(Date:2/23/2017)... SEATTLE , Feb. 23, 2017  Seattle,s upscale Capitol ... like a strange place for a head lice treatment salon ... nestled between a Tuscan restaurant and a French bistro on ... it,s perfect. "We aren,t just any old lice clinic, we ... to feel comfortable, and release some of the stigma associated ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
Breaking Biology News(10 mins):